What? An IP in preclinical mean it hasn't even proven to work to even commence Ph1 clinical trial so why would investor consider that as an IP with any valuation???? HER-Vaxx is way too expensive to commence Ph3 clinical trial by themself.
What? An IP in preclinical mean it hasn't even proven to work to...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $97.07M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.4¢ | 1.2¢ | $304.8K | 23.56M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 57 | 13718532 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 5374446 | 13 |
View Market Depth
| Last trade - 16.10pm 19/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |